Cabergoline for the Treatment of Pituitary Adenomas

21 September 2012

Dr. Samson is Assistant Professor of Medicine at the Baylor Clinic, Baylor College of Medicine in Houston, Texas. Her clinical interests include pituitary disorders, cushing's disease and acromegaly.

Dr. Samson discusses the use of cabergoline for the treatment of different types of pituitary adenomas, the potential for withdrawal off of cabergoline, and the current evidence regarding the use of this class of medications (dopamine agonists) and heart valve disease that has come from Parkinson's disease literature.

 

  • Susan Samson, MD, PhD, FRCPC, FACE
    Assistant Professor of Medicine
    Baylor College of Medicine

Description

Dr. Samson is Assistant Professor of Medicine at the Baylor Clinic, Baylor College of Medicine in Houston, Texas. Her clinical interests include pituitary disorders, cushing's disease and acromegaly.

Dr. Samson discusses the use of cabergoline for the treatment of different types of pituitary adenomas, the potential for withdrawal off of cabergoline, and the current evidence regarding the use of this class of medications (dopamine agonists) and heart valve disease that has come from Parkinson's disease literature.

 

Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now